The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Molecular evolution of breast cancer
Abstract
Molecular analysis of invasive breast cancer and its precursors has furthered our understanding of breast cancer progression. In the past few years, new multi‐step pathways of breast cancer progression have been delineated through genotypic–phenotypic correlations. Nuclear grade, more than any other pathological feature, is strongly associated with the number and pattern of molecular genetic abnormalities in breast cancer cells. Thus, there are two distinct major pathways to the evolution of low‐ and high‐grade invasive carcinomas: whilst the former consistently show oestrogen receptor (ER) and progesterone receptor (PgR) positivity and 16q loss, the latter are usually ER/PgR‐negative and show Her‐2 overexpression/amplification and complex karyotypes. The boundaries between the evolutionary pathways of well‐differentiated/low‐grade ductal and lobular carcinomas have been blurred, with changes in E‐cadherin expression being one of the few distinguishing features between the two. In addition, lesions long thought to be precursors of breast carcinomas, such as hyperplasia of usual type, are currently considered mere risk indicators, whilst columnar cell lesions are now implicated as non‐obligate precursors of atypical ductal hyperplasia (ADH) and well‐differentiated ductal carcinoma in situ (DCIS). However, only through the combination of comprehensive morphological analysis and cutting‐edge molecular tools can this knowledge be translated into clinical practice and patient management. Copyright © 2005 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,728
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., van 't Veer, L. J., Dai, H., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,488
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429
Emmert-Buck, M. R., Bonner, R. F., Smith, P. D., Chuaqui, R. F., Zhuang, Z., Goldstein, S. R., Weiss, R. A., & Liotta, L. A. (1996) · Science · doi:10.1126/science.274.5289.998 · Cited by 2,534
Sotiriou, C., Neo, S.-Y., McShane, L. M., Korn, E. L., Long, P. M., Jazaeri, A., Martiat, P., Fox, S. B., Harris, A. L., & Liu, E. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732912100 · Cited by 1,993
Gene expression profiles of human breast cancer progression
Ma, X.-J., Salunga, R., Tuggle, J. T., Gaudet, J., Enright, E., McQuary, P., Payette, T., Pistone, M., Stecker, K., Zhang, B. M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931261100 · Cited by 887
Cytogenetic analysis by chromosome painting using dop‐pcr amplified flow‐sorted chromosomes
Telenius, H., Ponder, B. A. J., Tunnacliffe, A., Pelmear, A. H., Carter, N. P., Ferguson‐Smith, M. A., Behmel, A., Nordenskjöld, M., & Pfragner, R. (1992) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870040311 · Cited by 573
Analysis of Loss of Heterozygosity in 399 Premalignant Breast Lesions at 15 Genetic Loci
O'Connell, P., Pekkel, V., Allred, D. C., Fuqua, S. A. W., Osborne, C. K., & Clark, G. M. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.9.697 · Cited by 340
Buerger, H., Otterbach, F., Simon, R., Poremba, C., Diallo, R., Decker, T., Riethdorf, L., Brinkschmidt, C., Dockhorn-Dworniczak, B., & Boecker, W. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199903)187:4<396::aid-path286>3.0.co;2-l · Cited by 328
Lage, J. M., Leamon, J. H., Pejovic, T., Hamann, S., Lacey, M., Dillon, D., Segraves, R., Vossbrinck, B., González, A., Pinkel, D., et al. (2003) · Genome Research · doi:10.1101/gr.377203 · Cited by 261
Korsching, E., Packeisen, J., Agelopoulos, K., Eisenacher, M., Voss, R., Isola, J., van Diest, P. J., Brandt, B., Boecker, W., & Buerger, H. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000038508.86221.b3 · Cited by 238
Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast
Droufakou, S., Deshmane, V., Roylance, R., Hanby, A., Tomlinson, I., & Hart, I. R. (2001) · International Journal of Cancer · doi:10.1002/ijc.1208 · Cited by 229
Lakhani, S. R., Collins, N., Stratton, M. R., & Sloane, J. P. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.611 · Cited by 204
Self-citationMoinfar, F., Man, Y., Bratthauer, G. L., Ratschek, M., & Tavassoli, F. A. (2000) · PubMed · Cited by 198
Genetic alterations in ?normal? luminal and myoepithelial cells of the breast
Lakhani, S. R., Chaggar, R., Davies, S., Jones, C., Collins, N., Odel, C., Stratton, M. R., & O’Hare, M. J. (1999) · The Journal of Pathology · Cited by 166
Self-citationGenetic alterations in lobular breast cancer by comparative genomic hybridization
Nishizaki, T., Chew, K., Chu, L., Isola, J., Kallioniemi, A., Weidner, N., & Waldman, F. M. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19971021)74:5<513::aid-ijc6>3.0.co;2-6 · Cited by 161
Jones, C., Ford, E., Gillett, C., Ryder, K., Merrett, S., Reis-Filho, J. S., Fulford, L. G., Hanby, A. M., & Lakhani, S. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0731 · Cited by 139
Self-citationAmplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications.
Tanner, M., Tirkkonen, M., Kallioniemi, A. H., Holli, K. A., Collins, C. C., Kowbel, D., Gray, J. W., Kallioniemi, O., & Isola, J. (1995) · PubMed · Cited by 136
Cleton-Jansen, A. (2001) · Breast Cancer Research · doi:10.1186/bcr416 · Cited by 133
Simpson, P. T., Gale, T., Fulford, L. G., Reis-Filho, J. S., & Lakhani, S. R. (2003) · Breast Cancer Research · doi:10.1186/bcr624 · Cited by 129
Self-citationBuerger, H. (2000) · Molecular Pathology · doi:10.1136/mp.53.3.118 · Cited by 121
Boecker, W., Buerger, H., Schmitz, K., Ellis, I. O., van Diest, P. J., Sinn, H., Geradts, J., Diallo, R. I., Poremba, C., & Herbst, H. (2001) · The Journal of Pathology · doi:10.1002/path.982 · Cited by 112
Patterns of chromosomal imbalances in invasive breast cancer
Richard, F., Pacyna-Gengelbach, M., Schlüns, K., Fleige, B., Winzer, K. J., Szymaś, J., Dietel, M., Petersen, I., & Schwendel, A. (2000) · International Journal of Cancer · Cited by 100
Gong, G., DeVries, S., Chew, K., Cha, I., Ljung, B., & Waldman, F. M. (2001) · PubMed · Cited by 99
Loss of Heterozygosity in Fibrocystic Change of the Breast
Washington, C., Dalbègue, F., Abreo, F. W., Taubenberger, J. K., & Lichy, J. H. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64543-9 · Cited by 79
Aubele, M. M., Cummings, M. C., Mattis, A. E., Zitzelsberger, H. F., Walch, A. K., Kremer, M., Höfler, H., & Werner, M. (2000) · Diagnostic Molecular Pathology · doi:10.1097/00019606-200003000-00003 · Cited by 79
Larson, P. S., Morenas, A. D. L., Bennett, S. R., Cupples, L. A., & Rosenberg, C. L. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64180-6 · Cited by 77
Molecular Evolutionary Patterns in Breast Cancer
Shackney, S. E., & Silverman, J. F. (2003) · Advances in Anatomic Pathology · doi:10.1097/00125480-200309000-00003 · Cited by 76
Werner, M., Mattis, A. E., Aubele, M. M., Cummings, M. C., Zitzelsberger, H. F., Hutzler, P., & Höfler, H. (1999) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280050429 · Cited by 52
Zudaire, I., Odero, M. D., Caballero, C., et al. (2002) · Histopathology · doi:10.1046/j.1365-2559.2002.01413.x · Cited by 47
The role of E‐cadherin in low‐grade ductal breast tumourigenesis
Roylance, R. R., Droufakou, S., Gorman, P. A., et al. (2003) · The Journal of Pathology · doi:10.1002/path.1326 · Cited by 39
Distinct Genetic and Epigenetic Changes in Medullary Breast Cancer
Osin, P., Lu, Y., Stone, J., Crook, T., Houlston, R. S., Gasco, M., Gusterson, B. A., & SHIPLEY, J. M. (2003) · International Journal of Surgical Pathology · doi:10.1177/106689690301100301 · Cited by 31
Rakha, E. A., Pinder, S. E., Paish, C. E., & Ellis, I. O. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602144 · Cited by 31
Long term survivors of childhood brain cancer have an increased risk for cardiovascular disease
(2000) · Pure Amsterdam UMC · doi:10.1002/(sici)1097-0142(20000501)88:9
Cited by
Feng, Y., Spezia, M., Huang, S., Yuan, C., Zeng, Z., Zhang, L., Ji, X., Liu, W., Huang, B., Luo, W., et al. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.05.001 · Cited by 1,486
Tumor-Infiltrating CD8+Lymphocytes Predict Clinical Outcome in Breast Cancer
Mahmoud, S. M. A., Paish, E. C., Powe, D. G., Macmillan, R. D., Grainge, M. J., Lee, A. H. S., Ellis, I. O., & Green, A. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5037 · Cited by 1,367
Triple negative tumours: a critical review
Reis‐Filho, J. S., & Tutt, A. N. J. (2008) · Histopathology · doi:10.1111/j.1365-2559.2007.02889.x · Cited by 884
Self-citationBreast cancer: origins and evolution
Polyak, K. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33295 · Cited by 697
Subik, K., Lee, J.-F., Baxter, L., Strzepek, T., Costello, D., Crowley, P., Xing, L., Hung, M.-C., Bonfiglio, T., Hicks, D. G., et al. (2010) · Breast Cancer: Basic and Clinical Research · doi:10.1177/117822341000400004 · Cited by 573
Metadata
- Authors
- Simpson, P. T., Reis‐Filho, J. S., Gale, T., & Lakhani, S. R.
- Venue
- The Journal of Pathology
- Publisher
- Wiley
- Published
- 2005-01
- Volume
- 205
- Issue
- 2
- Pages
- 248-254
- ISSN
- 0022-3417 (ISSN-L)
- 1096-9896
- OpenAlex
- W2071906932
- Cited by
- 517
- References
- 38
- FWCI
- 25.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.